Tithonia Group
Specialty pharma group that runs a medicine licensing and distribution platform and product brands for prescribers and patients in Europe
Highlights
- New on EvolcAdded 2026-10-31
About Tithonia Group
Tithonia Group is a life sciences group that builds and operates specialty pharmaceutical businesses. Its brands include Simple Pharma, a pharmaceutical platform company that holds licences and distributes medicines in 30+ countries across Europe and worldwide; Androlabs, a men's health pharmaceutical company launched in 2022; and Tamrisa, a specialised pharma venture focused on antimicrobial resistance, with which Tithonia partnered in 2024.
Simple Pharma provides the operational infrastructure that brings products to market, which lets Androlabs focus on prescribers and patients. The group's strategy covers acquisitions and integrations of pharmaceutical products, organic growth of specialty products, lean tech-enabled operations and pharmaceutical product development.
The company is registered in London, where it is headquartered, and was founded in 2020. The website states a team of 40+ people across 7 countries and locations across Europe.
Product: Pharmaceutical platform services (licensing, distribution and operations for medicines) and specialty pharma products under the Androlabs and Tamrisa brands.
Jobs at Tithonia Group
More biotech & pharma companies
Titian Software
Sample management software for life science labs, including pharma, biotech, CROs and biobanksNew on EvolcRemote-friendlyTiziana Life Sciences
Clinical-stage biotech developing intranasal and fully human antibody immunotherapies for multiple sclerosis, Alzheimer's and ALSNew on EvolcTorrent Pharma (UK)
Distributes generic prescription medicines to UK pharmacies, wholesalers and hospitalsNew on EvolcRemote-friendlyTozaro
Synthetic Smart Polymer affinity ligands for purifying viral vectors and biologics, for cell and gene therapy manufacturersNew on EvolcTreos Bio
Develops peptide-based cancer immunotherapies for patients and pharmaceutical development partnersNew on EvolcTrimtech Therapeutics
Develops small-molecule protein degraders for Alzheimer's, Parkinson's and other neurodegenerative and inflammatory diseasesYoung companyNew on Evolc
Website technologies
Older, unverified list. Detection dates and supporting evidence are not yet available.
- Framer
- Google Analytics 4
- Workable